PD Dr. Michael Hoffmeister

PD Dr. Michael Hoffmeister

PD Dr. Michael Hoffmeister


Stellvertretender Abteilungsleiter, Gruppenleiter


+49 (0)6221 42-1303


+49 (0)6221 42-1302


Im Neuenheimer Feld 581


S 1.200

Stellvertretender Abteilungsleiter
Gruppenleiter "Molekular-pathologische Epidemiologie"


Risikofaktoren und prognostische Faktoren
Molekular-pathologische Epidemiologie


Wissenschaftliche Studien, Projekte, Aktivitäten

DACHS-Studie, Principal Investigator (seit 2011)
IMPACT Konsortium, Netzwerkkoordinator (seit 2009), Co-Principal Investigator
KolosSal-Studie, Co-Principal Investigator (seit 2009)
SAMS-Studie, Co-Principal Investigator (seit 2012)
GECCO Consortium (Seattle, USA), Co-Investigator (seit 2009)
RAPS-Studie, Co-Investigator (seit 2014)
DARIO-Studie, Co-Investigator (seit 2015)

Gewähltes Mitglied des Wissenschaftlichen Rats des DKFZ (seit 2015)


Aktuelle PhD-Doktoranden

Elizabeth Alwers
Stefanie Bienert
Prudence Carr
Min Jia



Artikel in PubMed 


Ausgewählte Publikationen


Brenner H, Schrotz-King P, Holleczek B, Katalinic A, Hoffmeister M. Declining Bowel Cancer Incidence and Mortality in Germany. Dtsch Arztebl Int 2016;113(7):101-6

Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014;348:g2467

Brenner H, Chang-Claude J, Jansen L, Knebel P, Stock C, Hoffmeister M. Reduced risk of colorectal cancer up to 10 y after screening, surveillance, or diagnostic colonoscopy. Gastroenterology 2013;146(3);709-17

Hoffmeister M, Schmitz S, Karmrodt E, Stegmaier C, Haug U, Arndt V, Brenner H. Male sex and smoking have a larger impact on the prevalence of colorectal neoplasia than family history of colorectal cancer. Clin Gastroenterol Hepatol 2010;8(10):870-6

Risikofaktoren und prognostische Factoren
Carr PR, Jansen L, Walter V, Kloor M, Roth W, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M. Associations of red and processed meat with survival after colorectal cancer and differences according to timing of dietary assessment. Am J Clin Nutr 2016;103(1):192-200

Hoffmeister M, Jansen L, Rudolph A, Toth C, Kloor M, Roth W, Bläker H, Chang-Claude J, Brenner H. Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment. J Natl Cancer Inst 2015;107(6):djv045

Carr PR, Walter V, Brenner H, Hoffmeister M. Meat subtypes and their association with colorectal cancer: systematic review and meta-analysis. Int J Cancer 2015;138(2):293-302

Molekular-pathologische Epidemiologie
Jia M, Jansen L, Walter V, Tagscherer K, Roth W, Herpel E, Kloor M, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M. No association of CpG island methylator phenotype and colorectal cancer survival: population-based study. Br J Cancer 2016 [Epub ahead of print]

Hoffmeister M*, Bläker H*, Kloor M, Roth W, Toth C, Herpel E, Frank B, Schirmacher P, Chang-Claude J, Brenner H (*equal contribution). Body mass index and microsatellite instability in colorectal cancer: a population-based case-control study. Cancer Epidem Biomarkers Prev 2013;22(12):2303-11

Bläker H, Hildebrandt B, von Winterfeld M, Ingold-Heppner B, Jansen L, Roth W, Kloor M, Schirmacher P, Dietel M, Tao S, Jansen L, Chang-Claude J, Brenner H, Hoffmeister M. Lymph node count and prognosis in colorectal cancer: the influence of examination quality. Int J Cancer 2015;136(8):1957-66


nach oben